TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

1.446 Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases. Treatment guidelines
2006. Morb Mortal Wkly Rep 2006;55(RR-11):1-94.
1.447 Hollier LM et al. Treatment of sexually transmitted infections in women. Infect Dis Clin North Am
2008;22:665-91.
1.448 Lusk MJ et al. Cervicitis: a review. Curr Opin Infect Dis 2008;21:49–55.
1.449 Ross J et al. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS
2007;18:662-6.
1.450 Walker CK et al. Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease
Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis
2007;44(suppl. 3):S111-22.
1.451 Faro C et al. Postoperative pelvic infections. Infect Dis Clin North Am 2008;22:653-663.
1.452 Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis 2010;23:
83-7.
1.453 Lareau SM et al. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am
2008;22:693-708.
1.454 Haggerty CL et al. Newest approaches to treatment of pelvic inflammatory disease: a review of recent
randomized clinical trials. Clin Infect Dis 2007;44:953-60.
1.455 Short VL et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae
infection among women with pelvic inflammatory disease. Clin Infect Dis 2009;48:41-7.
1.456 Haggerty C et al. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr
Opin Infect Dis 2008;21:65-9.
1.457 Eckert LO. Acute vulvovaginitis. N Engl J Med 2006;355:1244-52.
1.458 Hay P. Recurrent bacterial vaginosis. Curr Opin Infect Dis 2009;22:82–6.
1.459 Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am 2008;22:637-
52.
1.460 Fethers KA et al. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.
Clin Infect Dis 2008;47:1426-35.
1.461 Verstraelen H et al. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect
Ther 2009;7:1109-24.
1.462 Okun N et al. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic
review. Obstet Gynecol 2005;105:857-68.
1.463 Sobel JD. What‘s new in bacterial vaginosis and trichomoniasis? Infect Dis Clin North Am 2005;19:
387-406.
1.464 Spence D et al. Vaginal discharge. Br Med J 2007;335:1147-51.
1.465 Marrazzo JM. Evolving issues in understanding and treating bacterial vaginosis. Expert Rev Anti Infect
Ther 2004;2:913-22.
1.466 Bradshaw CS et al. High recurrence rates of bacterial vaginosis over the course of 12 months after
oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86.
1.467 De Backer E et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis 2006;6:51.
1.468 Ugwumadu A et al. Effect of early clindamycin on late miscarriage and preterm delivery in asymptomatic
women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet
2003;361:983-8.
1.469 Yudin MH et al. Screening and management of bacterial vaginosis in pregnancy. J Obstet Gynaecol
Can 2008;30:702-8.
1.470 Schwebke JR et al. A randomized trial of the duration of therapy with metronidazole plus or minus
azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007;44:213-9.
1.471 Centers for Disease Control and Prevention (CDC). Update to CDC‘s sexually transmitted diseases
guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Morb Mortal Wkly Rep 2007;56:332-6.
1.472 Ghanem KG et al. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect
Dis Clin North Am 2005;19:351-65.
1.473 Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases. Treatment guide-
lines 2006. Morb Mortal Wkly Rep 2006;55(RR-11):1-94.
1.474 Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia 2008;40:
76-80.
1.475 Edwards SK. European guideline for the management of balanoposthitis. Int J STD AIDS 2001;12
(suppl. 3):68-72.
1.476 Lisboa C et al. Infectious balanoposthitis: management, clinical and laboratory features. Int J Dermatol
2009;48:121-4.
1.477 Horner PJ. European guideline for the management of epididymo-orchitis and syndromic management
of acute scrotal swelling. Int J STD AIDS 2001;12(suppl. 3):88-93.
1.478 Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355:
1690-8.
1.479 McNaughton Collins M et al. Diagnosis and treatment of chronic abacterial prostatitis: a systematic
review. Ann Intern Med 2000;133:367-81.
1.480 Alexander RB et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome.
Ann Intern Med 2004;141:581-9.
1.481 Lipsky BA et al. Treatment of bacterial prostatitis. Clin Infect Dis 2010;50:1641-52.
1.482 Domingue GJ et al. Prostatitis. Clin Microbiol Rev 1998;11:604-13.
1.483 Wagenlehner FM et al. Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther 2003;1:
275-82.
1.484 Wagenlehner FM et al. Current challenges in the treatment of complicated urinary tract infections and
prostatitis. Clin Microbiol Infect 2006;12(suppl. 3):67-80.
1.485 Schaeffer AJ. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355:
1690-8.
1.486 Tosti R et al. Empiric antibiotics for acute infections of the hand. J Hand Surg 2010;35:125-8.
1.487 Clark DC. Common acute hand infections. Am Fam Physician 2003;68:2167-76.
1.488 Spann M et al. Hand infections: basic principles and management. Surg Infect 2004;5:210-20.
1.489 Rigopulos D et al. Acute and chronic paronychia. Am Fam Physician 2008;77:339-46.
1.490 Baddour LM et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015-
31.
1.491 Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350:
1422-9.